We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
-0.14%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.54%
AUM
$167B
AUM Growth
+$3.7B
Cap. Flow
+$8.65B
Cap. Flow %
5.19%
Top 10 Hldgs %
18.31%
Holding
7,698
New
1,244
Increased
2,720
Reduced
2,447
Closed
981

Sector Composition

Rank Sector Weight
1 Technology 7.39%
2 Financials 6.67%
3 Healthcare 6.18%
4 Industrials 4.97%
5 Consumer Discretionary 4.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TECX
2901
Tectonic Therapeutic
TECX
$529M
$4.69M ﹤0.01%
69,996
+22,636
+48% +$1.86M
NAT icon
2902
Nordic American Tanker
NAT
$1.38B
$4.69M ﹤0.01%
1,830,436
+1,319,742
+258% +$3.31M
AMRX icon
2903
Amneal Pharmaceuticals
AMRX
$5.85B
$4.68M ﹤0.01%
877,304
+54,040
+7% +$272K
AQUA
2904
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
$4.68M ﹤0.01%
124,589
+53,978
+76% +$1.95M
ESXB
2905
DELISTED
Community Bankers Trust Corporation
ESXB
$4.68M ﹤0.01%
411,369
-60,311
-13% -$651K
CGEM icon
2906
Cullinan Oncology
CGEM
$1.01B
$4.67M ﹤0.01%
207,030
-26,631
-11% -$712K
ICUI icon
2907
CALL
ICU Medical
ICUI
$4.21B
$4.67M ﹤0.01%
20,000
-20,000
-50% -$4.19M
EWU icon
2908
iShares MSCI United Kingdom ETF
EWU
$4.14B
$4.67M ﹤0.01%
144,728
-51,812
-26% -$1.7M
MOR
2909
DELISTED
MorphoSys AG American Depositary Shares
MOR
$4.66M ﹤0.01%
395,839
+69,208
+21% +$1M
TITN icon
2910
Titan Machinery
TITN
$396M
$4.65M ﹤0.01%
179,412
+111,913
+166% +$3.14M
EVH icon
2911
CALL
Evolent Health
EVH
$348M
$4.64M ﹤0.01%
+149,700
New +$3.59M
PAR icon
2912
PAR Technology
PAR
$699M
$4.64M ﹤0.01%
+75,435
New +$4.84M
VERU icon
2913
Veru
VERU
$36M
$4.64M ﹤0.01%
54,359
+43,639
+407% +$3.46M
MPC icon
2914
CALL
Marathon Petroleum
MPC
$92.4B
$4.64M ﹤0.01%
75,000
GIA.U
2915
DELISTED
GigCapital 5, Inc. Units, each consisting of one share of common stock and one whole redeemable warrant
GIA.U
$4.63M ﹤0.01%
+450,000
New +$4.6M
FRON
2916
DELISTED
Frontier Acquisition Corp. Class A Ordinary Shares
FRON
$4.58M ﹤0.01%
471,425
+217,437
+86% +$2.11M
ARYE
2917
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$4.58M ﹤0.01%
+463,083
New +$4.6M
KCGI.U
2918
DELISTED
Kensington Capital Acquisition Corp. V Units, each consisting of one Class A ordinary share and three-fourths of one redeemable warrant
KCGI.U
$4.57M ﹤0.01%
+448,173
New +$4.53M
ACMR icon
2919
ACM Research
ACMR
$5.42B
$4.57M ﹤0.01%
124,596
-566,229
-82% -$17.3M
DSX icon
2920
Diana Shipping
DSX
$302M
$4.56M ﹤0.01%
1,139,420
+732,277
+180% +$2.42M
RTPYU
2921
DELISTED
Reinvent Technology Partners Y Unit
RTPYU
$4.55M ﹤0.01%
450,854
-1,137,164
-72% -$11.4M
BBBY
2922
DELISTED
Bed Bath & Beyond Inc
BBBY
$4.55M ﹤0.01%
263,284
-20,937
-7% -$566K
SLACU
2923
DELISTED
Social Leverage Acquisition Corp I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant
SLACU
$4.54M ﹤0.01%
458,659
-62,238
-12% -$617K
Y
2924
DELISTED
Alleghany Corp
Y
$4.54M ﹤0.01%
7,278
-972
-12% -$642K
AXSM icon
2925
Axsome Therapeutics
AXSM
$11.2B
$4.53M ﹤0.01%
137,325
-79,514
-37% -$3.1M

Similar funds

Millennium Management's Q3 2021 Portfolio in Review

As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.

By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $694M trimmed.

  • Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
  • Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
  • Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
  • Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
  • Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
  • Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
  • Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.

Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.